Phase 2 study of everolimus monotherapy in patients with nonfunctioning neuroendocrine tumors or pheochromocytomas/paragangliomas - Concepedia

Concepedia

Publication | Open Access

Phase 2 study of everolimus monotherapy in patients with nonfunctioning neuroendocrine tumors or pheochromocytomas/paragangliomas

DOI Full Paper Access

94

Citations

23

References

2012

Year

Do‐Youn Oh, Tae‐Won Kim, Young Suk Park, Sang Joon Shin, Seong Hoon Shin, Eun‐Kee Song, Hyo Jin Lee, Kewn‐wook Lee, Yung‐Jue Bang

Abstract

Everolimus was associated with high therapeutic efficacy and tolerability in patients with nonfunctioning NETs, and demonstrated modest efficacy in patients with pheochromocytomas/paragangliomas.

References

	Year	Citations

Page 1